Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;42(1):1-7.
doi: 10.1007/s00595-011-0058-8. Epub 2011 Nov 25.

Role of tumor-associated macrophages in the progression of hepatocellular carcinoma

Affiliations
Review

Role of tumor-associated macrophages in the progression of hepatocellular carcinoma

Ken Shirabe et al. Surg Today. 2012 Jan.

Abstract

Recent studies have shown that the tumor microenvironment plays an important role in cancer progression. Tumor-associated macrophages (TAMs), in particular, have been found to be associated with tumor progression. Macrophages have multiple biological roles, including antigen presentation, target cell cytotoxicity, removal of foreign bodies, tissue remodeling, regulation of inflammation, induction of immunity, thrombosis, and endocytosis. Recent immunological studies have identified two distinct states of polarized macrophage activation: the classically activated (M1) and the alternatively activated (M2) macrophage phenotypes. Bacterial moieties such as lipopolysaccharides and the Th1 cytokine interferon-γ polarize macrophages toward the M1 phenotype. The M2 polarization was discovered as a response to the Th2 cytokine interleukin-4. In general, M2 macrophages exert immunoregulatory activity, participate in polarized Th2 responses, and aid tumor progression. TAMs have recently been found to play an important role in hepatocellular carcinoma (HCC) progression. Based on the properties of TAMs, obtained from pathological examination of resected specimens, we have identified new therapeutic approaches, involving the targeting of TAMs with adjuvant therapy after hepatic resection for HCC. This review discusses the roles of TAM in HCC progression and the possibility of new therapies targeting TAMs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14978-83 - PubMed
    1. Int J Cancer. 1982 May 15;29(5):575-81 - PubMed
    1. Surg Today. 2011 Jan;41(1):101-6 - PubMed
    1. Cancer Biol Ther. 2009 Dec;8(24):2329-38 - PubMed
    1. J Immunol. 2006 Nov 15;177(10):7303-11 - PubMed

MeSH terms

LinkOut - more resources